Method | Order |
---|
1 | 2 | 3 | 4 | 5 |
---|
Pearson-SP | Path1 (152.8) | Path2 (69.90) | Path3 (69.01) | Path4 (59.54) | Path5 (32.35) |
Spearman-SP | Path1 (246.54) | Path2 (154.98) | Path4 (125.08) | Path5 (96.00) | Path3 (66.61) |
DC-SP | Path1 (57.84) | Path3 (41.32) | Path2 (35.91) | Path4 (31.42) | Path6 (24.32) |
MIC-SP | Path3 (3063.17) | Path1 (1136.26) | Path6 (1099.96) | Path2 (743.01) | Path4 (380.01) |
MI-SP | Path3 (60.95) | Path6 (39.72) | Path2 (33.01) | Path5 (25.26) | Path1 (21.32) |
MCC-SP | Path1 (13.80) | Path3 (12.32) | Path4 (8.87) | Path6 (8.84) | Path2 (7.42) |
- Note: The pathway importance scores (PISs) were shown in the parenthesis. Note that the PIS is only comparable across one specific method
- Path1: APOE genotype →APOE gene expression→GRIN2A → CAPN2 → MAPT→AD
- Path2: APOE genotype →APOE gene expression →GRIN2A → MAPK1 → CASP3 → AD
- Path3: APOE genotype →APOE gene expression →GRIN2A → NOS1 → AD
- Path4: APOE genotype →APOE gene expression →CACNA1C → CAPN2 → MAPT→AD
- Path5: APOE genotype →APOE gene expression→CACNA1C → MAPK1 → CASP3 → AD
- Path6: APOE genotype →APOE gene expression→CACNA1C → NOS1 → AD